Blood Sugar and Heart Failure in the ICU
Part of Heart & circulation clinical trials.
This study looks at how blood sugar levels affect recovery and survival in the ICU for people whose heart failure worsened suddenly. Your blood sugar will be monitored while you receive standard care, to see if it relates to how well you do.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently in the intensive care unit (ICU) because your heart failure suddenly got worse (acute decompensated heart failure).
- You are not taking long-term steroid medications (like prednisone).
- Your heart failure is not caused by a lung disease affecting the right side of the heart.
- You do not have an active cancer diagnosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how cells talk to each other in people who have both diabetes and heart failure. It may help doctors understand these conditions better.
This trial tests whether using a continuous glucose monitor (CGM) helps people with both heart failure and diabetes manage their blood sugar better. It follows patients from hospital admission through discharge.
This study looks at how changes in blood sugar levels might help predict recovery in patients with a serious infection (sepsis) in the ICU. It tests whether closely monitoring glucose fluctuations can help doctors better understand the course of the illness.
This study looks at how people with and without diabetes recover from acute heart failure (a sudden worsening). It aims to compare short-term outcomes in the hospital.
This study looks at how well continuous glucose monitors (small sensors under the skin that track sugar levels) work in ICU patients who need insulin. If you are in the ICU, on insulin, and already have a sensor, you may be able to join.
This study compares two ways of checking blood sugar in the ICU: a continuous monitor (sensor under the skin) versus intermittent finger sticks. It aims to see which method is better for managing blood sugar levels in critically ill patients on insulin.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.